Subclinical thyroid dysfunction and cognitive decline in old age

Wijsman, L.W., de Craen, A.J.M., Trompet, S., Gussekloo, J., Stott, D.J. , Rodondi, N., Welsh, P. , Jukema, J.W., Westendorp, R.G.J. and Mooijaart, S.P. (2013) Subclinical thyroid dysfunction and cognitive decline in old age. PLoS ONE, 8(3), e59199. (doi:10.1371/journal.pone.0059199) (PMID:23554996) (PMCID:PMC3595244)

[img]
Preview
Text
78621.pdf - Published Version
Available under License Creative Commons Attribution.

269kB

Abstract

<p>Background: Subclinical thyroid dysfunction has been implicated as a risk factor for cognitive decline in old age, but results are inconsistent. We investigated the association between subclinical thyroid dysfunction and cognitive decline in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).</p> <p>Methods: Prospective longitudinal study of men and women aged 70–82 years with pre-existing vascular disease or more than one risk factor to develop this condition (N = 5,154). Participants taking antithyroid medications, thyroid hormone supplementation and/or amiodarone were excluded. Thyroid function was measured at baseline: subclinical hyper- and hypothyroidism were defined as thyroid stimulating hormones (TSH) <0.45 mU/L or >4.50 mU/L respectively, with normal levels of free thyroxine (FT4). Cognitive performance was tested at baseline and at four subsequent time points during a mean follow-up of 3 years, using five neuropsychological performance tests.</p> <p>Results: Subclinical hyperthyroidism and hypothyroidism were found in 65 and 161 participants, respectively. We found no consistent association of subclinical hyper- or hypothyroidism with altered cognitive performance compared to euthyroid participants on the individual cognitive tests. Similarly, there was no association with rate of cognitive decline during follow-up.</p> <p>Conclusion: We found no consistent evidence that subclinical hyper- or hypothyroidism contribute to cognitive impairment or decline in old age. Although our data are not in support of treatment of subclinical thyroid dysfunction to prevent cognitive dysfunction in later life, only large randomized controlled trials can provide definitive evidence.</p>

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Welsh, Dr Paul and Stott J, Professor David
Authors: Wijsman, L.W., de Craen, A.J.M., Trompet, S., Gussekloo, J., Stott, D.J., Rodondi, N., Welsh, P., Jukema, J.W., Westendorp, R.G.J., and Mooijaart, S.P.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:PLoS ONE
Publisher:Public Library of Science
ISSN:1932-6203
Published Online:12 March 2013
Copyright Holders:Copyright © 2013 The Authors
First Published:First published in PLoS ONE 8(3):e59199
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record